| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 31.219 | 187.760 | 139.218 | 30.682 | 57.100 | 280.131 | 69.046 | 101.233 | 116.183 |
| Total Income - EUR | - | 31.219 | 244.522 | 139.218 | 30.682 | 110.643 | 280.131 | 70.686 | 118.505 | 116.167 |
| Total Expenses - EUR | - | 10.273 | 115.156 | 97.909 | 71.253 | 128.161 | 141.686 | 104.442 | 98.424 | 75.208 |
| Gross Profit/Loss - EUR | - | 20.947 | 129.365 | 41.308 | -40.570 | -17.518 | 138.444 | -33.756 | 20.081 | 40.959 |
| Net Profit/Loss - EUR | - | 20.634 | 127.487 | 39.916 | -40.877 | -18.415 | 135.699 | -34.463 | 18.896 | 34.260 |
| Employees | - | 3 | 3 | 3 | 3 | 3 | 5 | 4 | 4 | 2 |
Check the financial reports for the company - Neurofiziomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 136 | 58.035 | 84.515 | 74.460 | 13.384 | 5.564 | 1.814 | 813 | 878 |
| Current Assets | - | 25.241 | 78.132 | 88.364 | 56.065 | 87.967 | 245.940 | 109.569 | 13.572 | 52.735 |
| Inventories | - | 0 | 5.366 | 5.267 | 5.371 | 5.067 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 4.228 | 2.733 | 5.029 | 3.414 | 441 | 829 | 2.813 | 822 |
| Cash | - | 25.241 | 68.538 | 80.364 | 45.665 | 79.486 | 245.498 | 108.740 | 10.759 | 51.913 |
| Shareholders Funds | - | 21.748 | 128.801 | 166.353 | 122.254 | 101.522 | 234.969 | -33.247 | -14.249 | 20.090 |
| Social Capital | - | 1.113 | 1.095 | 1.074 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | - | 11.714 | 7.366 | 7.005 | 8.776 | 9.325 | 17.001 | 156.142 | 34.053 | 33.662 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurofiziomed Srl